🔺 What to do when markets are at an all-time high? Find smart bargains, like these.See Undervalued Stocks

10x Genomics releases Visium HD for spatial gene analysis

EditorEmilio Ghigini
Published 03/26/2024, 09:29 AM
TXG
-

PLEASANTON, Calif. - 10x Genomics, Inc. (NASDAQ: NASDAQ:TXG), a company specializing in single cell and spatial biology, has launched Visium HD Spatial Gene Expression, a new product designed to enable researchers to conduct whole transcriptome analysis from formalin-fixed paraffin-embedded (FFPE) tissue sections at a resolution comparable to that of single cells.

Announced today, Visium HD is characterized by its ability to map gene expression with high precision, which is expected to enhance the study of complex biological tissues. The product combines spatial gene expression data with histological images, allowing a more detailed examination of FFPE tissue samples.

According to Michael Schnall-Levin, Founding Scientist and Chief Technology Officer at 10x Genomics, "Visium HD is a game-changer for spatial discovery research." He expressed confidence that the product, which he described as the most requested in the company's history, would significantly impact scientific research.

Visium HD boasts several features, including a next-generation slide architecture that provides transcript data in 2 x 2 µm barcoded squares, enabling the resolution of fine anatomical structures and cell types at a single cell-scale. It also offers compatibility with human or mouse FFPE samples and integrates with analytical tools such as Space Ranger and Loupe Browser for data exploration.

To introduce Visium HD to the scientific community, 10x Genomics will host a webinar on April 2, 2024. The company's products are widely used in various fields, including oncology, immunology, and neuroscience, contributing to advancements in the understanding of health and disease.

The launch of Visium HD is based on a press release statement from 10x Genomics and reflects the company's ongoing efforts to provide innovative solutions for the analysis of biological systems.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.